What We Learned From a Deep Dive into Neuroscience Research Giving

What We Learned From a Deep Dive into Neuroscience Research Giving

We recently published an in-depth paper on trends in neuroscience research funding as part of IP’s State of American Philanthropy project. Author Mike Scutari takes a look at some of the report’s key findings.

Read More

This Small but Mighty Research Hub Is Expanding. Here’s Who’s Helping Make That Happen

This Small but Mighty Research Hub Is Expanding. Here’s Who’s Helping Make That Happen

Since 1963, Salk Institute scientists have been advancing our knowledge of cancer, aging, infectious disease and more. With a new seven-year, $750 million fundraising goal, the aim is to grow both its facilities and research ranks.

Read More

COVID Won't be the Last Pandemic. A Top Biomedical Funder Seeks to Get Ahead of Emerging Pathogens

COVID Won't be the Last Pandemic. A Top Biomedical Funder Seeks to Get Ahead of Emerging Pathogens

With a $100 million commitment, the Howard Hughes Medical Institute is the latest funder backing research to prepare for pathogens with the potential to threaten human health, or even trigger new pandemics. 

Read More

A Top Science Funder Wants to Keep Ukraine's Scientists at the Blackboard

A Top Science Funder Wants to Keep Ukraine's Scientists at the Blackboard

The war in Ukraine offers scope for funders to draw on their strengths to assist the embattled nation. For the Simons Foundation, that means helping Ukraine's physicists, biologists and other scientists continue their work.

Read More

Sergey Brin's Off-the-Radar Foundation Is Huge — and Growing Fast. Here’s What We Know About It

Sergey Brin's Off-the-Radar Foundation Is Huge — and Growing Fast. Here’s What We Know About It

Sergey Brin’s foundation has nearly $5 billion in assets and a portfolio spanning Parkinson’s disease, science and activism. It’s not known for transparency, but we do know a fair amount about what it supports and why.

Read More

“It Is Not a Panacea.” A Conversation About Philanthropy With ChatGPT

“It Is Not a Panacea.” A Conversation About Philanthropy With ChatGPT

AI can now write fairly convincingly on any topic a human throws at it, including philanthropy. So we naturally checked in with OpenAI’s chatbot ChatGPT to see if it could provide us with some hot takes on the state of the field.

Read More

What We Learned From a Deep Dive Into Cancer Research Giving

What We Learned From a Deep Dive Into Cancer Research Giving

As part of IP’s State of American Philanthropy project, we recently published an in-depth paper on trends in cancer research funding. Author Mike Scutari overviews what we learned and offers clues on what to expect going forward.

Read More

How a Grantmaker Focused on Rare Diseases Galvanizes Critical Research and Patient Support

How a Grantmaker Focused on Rare Diseases Galvanizes Critical Research and Patient Support

Over 25 million Americans live with rare diseases, and 90% of rare diseases do not have an FDA-approved treatment. We look at how the National Organization for Rare Disorders is moving the needle in this evolving field.

Read More

A Tech Winner Seeks Policy Change to Advance Racial Justice in the Industry

A Tech Winner Seeks Policy Change to Advance Racial Justice in the Industry

The Kapor Foundation has launched a multipronged initiative to allow communities of color access to the employment, economic and other benefits of the $2 trillion technology sector.

Read More

As Americans Grow Older, These Funders are Advancing the Field of Cognitive Aging Research

As Americans Grow Older, These Funders are Advancing the Field of Cognitive Aging Research

Millions will experience the effects of cognitive decline without being diagnosed with a neurological disease. Two prominent funders of cognitive aging research share how they are working to overcome this challenge.

Read More

This Research Funder Is on a Mission to Cure — and Destigmatize — Epilepsy

This Research Funder Is on a Mission to Cure — and Destigmatize — Epilepsy

CURE Epilepsy funds research to cure and more effectively treat a neurological condition that affects 3.4 million Americans. Part of that mission involves ending the silence that still surrounds epilepsy.

Read More

Funding Seeks to Shed Light on a Crucial Question: Are We Alone in the Universe?

Funding Seeks to Shed Light on a Crucial Question: Are We Alone in the Universe?

The question of life beyond Earth is compelling, both scientifically and spiritually. As new technology reveals multitudes of planets beyond Earth, the quest to identify signatures of extraterrestrial life is drawing more support.

Read More

“Explore the Gaps.” A Closer Look at the Kavli Foundation’s Neuroscience Grantmaking

“Explore the Gaps.” A Closer Look at the Kavli Foundation’s Neuroscience Grantmaking

The Kavli Foundation is one of philanthropy’s most impactful supporters of neuroscience research. We check with Life Sciences Director Amy Bernard about the funder’s grantmaking priorities and an emerging area of focus.

Read More

The Bezos Family Committed $710 Million to Disease Research. Here’s How That Came Together

The Bezos Family Committed $710 Million to Disease Research. Here’s How That Came Together

The Bezos family’s mega-commitment to the Fred Hutchinson Cancer Center will fund cancer and infectious disease research. The gift has a 20-year backstory, and offers a peek at how the fantastically wealthy clan operates.

Read More

Of Mice and Men: How Paul Allen's Giving Set the Stage for an Ambitious Effort to Map the Human Brain

Of Mice and Men: How Paul Allen's Giving Set the Stage for an Ambitious Effort to Map the Human Brain

Twenty years ago, Paul Allen's Institute for Brain Science launched with a project to map the mouse brain. Now, the NIH has tapped the institute to manage a global collaboration to map the human brain.

Read More

Taking on Paralysis, the Christopher & Dana Reeve Foundation Seeks to "Care and Cure"

Taking on Paralysis, the Christopher & Dana Reeve Foundation Seeks to "Care and Cure"

Once viewed as the “graveyard of neuroscience,” the field of spinal cord injury has made headway thanks to the Christopher & Dana Reeve Foundation. We check in with two leaders to discuss challenges and opportunities.

Read More

Why Three Deep-Pocketed Funders Joined Forces to Take on Bipolar Disorder

Why Three Deep-Pocketed Funders Joined Forces to Take on Bipolar Disorder

Bipolar disorder has been significantly understudied. In response, several donors with personal experience of the condition are working with the Milken Institute on a $150 million initiative to fund and coordinate global research.

Read More

Parkinson's Funders Take a Venture Philanthropy Approach to Speed Development of Treatments

Parkinson's Funders Take a Venture Philanthropy Approach to Speed Development of Treatments

The Parkinson's Foundation in the U.S. and Parkinson's U.K. have inked a new partnership to boost investment in treatments for the neurodegenerative condition that affects 10 million people worldwide.

Read More

New Funding Aims to Accelerate Treatments for Lupus, an Autoimmune Disease with Many Faces

New Funding Aims to Accelerate Treatments for Lupus, an Autoimmune Disease with Many Faces

Often missed or misdiagnosed, lupus disproportionately affects women of color in the U.S. Here’s how a leading lupus research funder is speeding along the development of much-needed treatments.

Read More

Seven Questions for Stephen Quake, the New Head of Science at Chan Zuckerberg Initiative

Seven Questions for Stephen Quake, the New Head of Science at Chan Zuckerberg Initiative

The Chan Zuckerberg Initiative recently named Stanford Professor Stephen Quake as its new head of science. We spoke about his new role leading CZI's ambitious mission to treat all human disease within the century.

Read More